폐암에서 5-aminolevulinic acid를 이용한 광역동내시경의 유용성
Usefulness of 5-aminolevulinic acid-photodynamic diagnosis in lung cancer
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Lung cancer remains the leading cause of cancer death despite 50 years of antismoking efforts and advances in treatment. Overall, the 5-year survival remains disappointing at 15%. The majority of lung cancers are inoperable at presentation, thereby limiting treatment options and the potential to cure. The best prognosis for lung cancer is expected when the diagnosis is made at an early stage of the disease. At present, the best way to diagnose lung cancer is a combination of three different screening tools: low-dose computed tomography (CT), sputum analyses, and fluorescence bronchoscopy. The tumor marking ability of 5-aminolevulinic acid (5-ALA) has been demonstrated. Inhalation of 5-ALA has been used to detect early lung cancer and is safe and reliable. The data of Yoon et al. in this issue describe the usefulness of photodynamic diagnosis with ALA inhalation.
Abstract
Lung cancer remains the leading cause of cancer death despite 50 years of antismoking efforts and advances in treatment. Overall, the 5-year survival remains disappointing at 15%. The majority of lung cancers are inoperable at presentation, thereby limiting treatment options and the potential to cure. The best prognosis for lung cancer is expected when the diagnosis is made at an early stage of the disease. At present, the best way to diagnose lung cancer is a combination of three different screening tools: low-dose computed tomography (CT), sputum analyses, and fluorescence bronchoscopy. The tumor marking ability of 5-aminolevulinic acid (5-ALA) has been demonstrated. Inhalation of 5-ALA has been used to detect early lung cancer and is safe and reliable. The data of Yoon et al. in this issue describe the usefulness of photodynamic diagnosis with ALA inhalation.
참고문헌 (10)
- Humphrey LL, "Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force", Ann Intern Med, 140, pp.740~753 (2004)
- Deppermann KM, "Lung cancer screening: where are we in 2004", Lung Cancer, 45(2), pp.S9S~S42 (2004)
- MacRedmond R, "Screening for lung cancer using low dose CT scanning: results of 2 year follow up", Thorax, 61, pp.54~56 (2006)
- Lam S, "Detection and localization of early lung cancer by fluorescence bronchoscopy", Cancer, 89(11), pp.2468~2473 (2000)
- McWilliams A, "Lung cancer screening: a different paradigm", Am J Respir Crit Care Med, 168, pp.1167~1173 (2003)
- Banerjee AK, "Flourescence bronchoscopy: clinical dilemmas and reseach opportunities", Thorax, 58, pp.266~271 (2003)
- 권선중, "자가 형광 기관지 내시경을 이용한 동시성 원발성 폐암의 진단", Tuberculosis and Respiratory Diseases, 60(6), pp.645~652 (2006), 대한결핵및호흡기학��
- 이연선, "기관지내 전암성 병변 발견을 위한 자가 형광 기관지내시경의 유용성", 대한내과학회지, 71(1), pp.67~74 (2006), 대한내과학회
- Baumgartner R, "Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer", J Photochem Photobiol B, 36, pp.169~174 (1996)
- Gamarra F, "5-Aminolevulinic acid-induced fluorescence in bronchial tumours: dependency on the patterns of tumour invasion", J Photochem Photobiol B, 73, pp.35~42 (2004)